Evaluation of the bronchospasmolytic activity of alupent and ipradol
Makel'skiĭ, V.V.; Iartsev, S.S.
Sovetskaia Meditsina 1974(9): 142-143
1974
ISSN/ISBN: 0038-5077 PMID: 4409508 Document Number: 75457
Document emailed within 1 workday
Related Documents
Berti, F.; Magni, F.; Rossoni, G.; Schiantarelli, P.; Bongrani, S.; Pasargiklian, R. 1988: New pharmacological data on the bronchospasmolytic activity of bamifylline Arzneimittel-Forschung 38(1): 40-44Schlimmer, P.; Heise, D.; Grohs, H. 1983: Synoptic evaluation of lung function in bronchospasmolytic therapy Praxis und Klinik der Pneumologie 37(Suppl 1): 1088-1090
Golovushkina, G.V.; Oranskiĭ, I.E. 1979: Comparative evaluation of the action of atropine, ephedrine and alupent on the contractile function of the heart in pulmonary tuberculosis with disordered bronchial patency Problemy Tuberkuleza 1: 30-33
Babic, J.; Taufer, I.; Scholtz, J. 1974: The use of Alupent in the prevention and treatment of premature labours Ceskoslovenska Gynekologie 39(5): 336-337
Doll, E.; Kröpelin, K. 1970: Bronchospasmolytic effect of methylephedrine Arzneimittel-Forschung 20(11): 1783-1786
Heller, K. 1972: Treatment of spastic bronchitis with a new bronchospasmolytic agent Wiener Medizinische Wochenschrift 122(42): 606-609
Schwabl, U.; Schwabl, H.; Ulmer, W.T. 1990: Reproducibility of the bronchospasmolytic effect of anticholinergic drugs and beta-sympathomimetics Pneumologie 44(Suppl 1): 358-359
Borkenstein, J. 1979: The distribution of ventilation and perfusion in the obstructive syndrome during nitroglycerin and bronchospasmolytic therapy Acta Medica Austriaca 6(1): 5-7
Banholzer, R.; Pook, K.H.; Stiasni, M. 1986: Synthesis of the bronchospasmolytic agent flutropium bromide and of some homologous and configuration isomeric compounds Arzneimittel-Forschung 36(8): 1161-1166
Napiórkowska, W.; Bromberg-Sznek, S.; Vertun, B.; Wolańska, A.; Tylewska, S. 1976: Effect of sympathomimetics (isoprenaline, alupent, salbutamol) on the level of free and esterified fatty acids in blood serum of patients with chronic pulmonary diseases Pneumonologia Polska 44(2): 107-112
Kandt, D. 1981: The reproducibility of the bronchospasmolytic effects of isoprenaline tests repeated after long intervals under ambulatory conditions Zeitschrift für Erkrankungen der Atmungsorgane 157(1): 70-73
Zhao, W.; Cong, L. 2004: Physical activity evaluation: metabolic equivalent intensity levels and evaluation of different physical activity Wei Sheng Yan Jiu 33(2): 246-249
Seo, M.; Okada, M.; Yao, T.; Okabe, N.; Maeda, K.; Oh, K. 1995: Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification American Journal of Gastroenterology 90(10): 1759-1763
Sigwald, J. 1974: Clinical evaluation of the parkinsonian state. Method of evaluation, with a punch-card system, of the gravity of signs and symptoms and of the degree of impairment of various types of activity La Clinica Terapeutica 70(6): 507-530
Crispens, C.G.; Sorenson, J.R. 1988: Evaluation of the anticancer activity of CuDIPS in SJL/J mice Anticancer Research 8(1): 77-79
Shoeb, H.A.; Korkor, M.I.; Tammam, G.H. 1978: Synthesis and molluscicidal activity evaluation of some nitroquinolines Die Pharmazie 33(9): 581-583
Juva, K.; Sulkava, R.; Ylikoski, R.; Erkinjuntti, T. 1990: Evaluation of social activity potential in dementia Duodecim; Laaketieteellinen Aikakauskirja 106(2): 170-175
Mrda, V.; Dangubić, V.; Vićovac, M.; Pavlica, R.; Mihajlović, M. 1988: Diagnosis and evaluation of pulmonary tuberculosis activity Vojnosanitetski Pregled 45(2): 114-116
Cherchi, A.; Raffo, M.; Bina, M.; Fonzo, R.; Maxia, G.; Esu, M.P. 1971: Objective evaluation of the therapeutic activity of iproveratril Minerva Cardioangiologica 19(3): 123-132
Shoeb, H.A. 1978: Synthesis and molluscicidal activity evaluation of some nitrosalicylanilides Arzneimittel-Forschung 28(9): 1550-1553